SHEILA OLIVER: Open Payments
NPI 1649991803 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 68 payments from 18 companies in 2025. Trend: 2023 $987 · 2024 $935 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $396 |
| Novo Nordisk Inc | 4 | $151 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Axsome Therapeutics, Inc. | 2 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $87 |
| Viatris Specialty LLC | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Radius Health, Inc. | 2 | $41 |
| Verona Pharma, Inc. | 2 | $31 |
Products named: VRAYLAR, Auvelity, Ozempic, UBRELVY, BREZTRI, INGREZZA, YUPELRI, CAPLYTA.
Industry payments across MO — which companies pay providers there.
